Pancreatic Cancer Research

ResearcherHarvard UniversityActive in the last 2 years

João A. Paulo

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-4291-413X; OpenAlex author ID A5026734370, A5155535513. Sources: OpenAlex.

Their work

Papers
7
Trials
0
Grants
0
Labs led
0
Collaborators
35
Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: 1 paper · 2020: 2 papers · 2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 2 papers

Papers 7

  1. Alprazolam Reduces Inflammatory Cytokine Production in Pancreatic Cancer-Associated Fibroblasts. Co-author DOI 10.1158/2767-9764.crc-25-0472↗
  2. KRAS inhibition drives adaptive surfaceome remodeling and reveals ALPP/ALPPL2 as a targetable vulnerability in pancreatic cancer Co-author DOI 10.64898/2026.10.01.756025↗
  3. Autophagy is required for proper cysteine homeostasis in pancreatic cancer through regulation of SLC7A11. Co-author DOI 10.1073/pnas.2021475118↗
  4. Autophagy promotes immune evasion of pancreatic cancer by degrading MHC-I. Co-author DOI 10.1038/s41586-020-2229-5↗
  5. Selective Alanine Transporter Utilization Creates a Targetable Metabolic Niche in Pancreatic Cancer. Co-author DOI 10.1158/2159-8290.cd-19-0959↗
  6. Mutations in RABL3 alter KRAS prenylation and are associated with hereditary pancreatic cancer. Co-author DOI 10.1038/s41588-019-0475-y↗
  7. A proteomic comparison of formalin-fixed paraffin-embedded pancreatic tissue from autoimmune pancreatitis, chronic pancreatitis, and pancreatic cancer. Co-author DOI 10.6092/1590-8577/1508↗

Closest collaborators

The 25 strongest of 35 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Joseph Douglas Mancias · 5 shared papers, 2019–2026 · strength 0.58
  2. Alec C. Kimmelman · 4 shared papers, 2019–2021 · strength 0.38
  3. Keisuke Yamamoto · 3 shared papers, 2020–2021 · strength 0.32
  4. Kathryn E. Maraszek · 1 shared paper, 2026 · strength 0.27
  5. Michael E. Feigin · 1 shared paper, 2026 · strength 0.27
  6. Hunter D. Reavis · 1 shared paper, 2026 · strength 0.27
  7. Douglas E. Biancur · 2 shared papers, 2020–2021 · strength 0.23
  8. Seth J. Parker · 2 shared papers, 2020–2021 · strength 0.23
  9. Subhadip Mukhopadhyay · 2 shared papers, 2020–2021 · strength 0.23
  10. Robert Singhung Banh · 2 shared papers, 2020–2021 · strength 0.23
  11. Jonathan M. DeLiberty · 1 shared paper, 2026 · strength 0.21
  12. Timothy Paul Heffernan · 1 shared paper, 2026 · strength 0.21
  13. Tobiloba E. Oni · 1 shared paper, 2026 · strength 0.21
  14. Brendan D. Parent · 1 shared paper, 2026 · strength 0.21
  15. Andrew J. Aguirre · 1 shared paper, 2026 · strength 0.21
  16. Clint A. Stalnecker · 1 shared paper, 2026 · strength 0.21
  17. Dafna Bar‐Sagi · 1 shared paper, 2020 · strength 0.09
  18. Madeleine M. LaRue · 1 shared paper, 2020 · strength 0.09
  19. Kate E.R. Hollinshead · 1 shared paper, 2020 · strength 0.09
  20. Joel Encarnación-Rosado · 1 shared paper, 2020 · strength 0.09
  21. Huamin Wang · 1 shared paper, 2020 · strength 0.09
  22. Seth J. Parker · 1 shared paper, 2020 · strength 0.09
  23. MARK Reid PHILIPS · 1 shared paper, 2020 · strength 0.09
  24. Anthony C. Venida · 1 shared paper, 2020 · strength 0.09
  25. Suprit Gupta · 1 shared paper, 2020 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.